Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2003
05/08/2003US20030087352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087351 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087350 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087349 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087348 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087347 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087346 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087345 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087343 Novel SLGP nucleic acid molecules and uses therefor
05/08/2003US20030087342 Matrix attachment regions and methods for use thereof
05/08/2003US20030087341 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease
05/08/2003US20030087340 Novel human leucine-rich repeat containing protein expressed predominately in nervous system tissues, HLRRNS1
05/08/2003US20030087339 Alzheimer's disease; Parkinson's disease; rheumatic disorders
05/08/2003US20030087338 Adhesive DOPA-containing polymers and related methods of use
05/08/2003US20030087337 Nucleotide sequences coding polypeptide for use in the biosynthesis of canthaxanthin; for use in cosmetics, pharmocology and animal feeds
05/08/2003US20030087323 Specific monoclonal antibody against terbinafine
05/08/2003US20030087317 Human NIM1 kinase
05/08/2003US20030087305 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/08/2003US20030087304 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/08/2003US20030087299 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/08/2003US20030087294 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
05/08/2003US20030087283 Use of fructose-1,6-bisphosphate aldolase for identifying new fungicidally active substances
05/08/2003US20030087275 DNA sequences for regulating transcription
05/08/2003US20030087270 Nucleotide sequences coding polypeptide for use in the detection, classification, prevention and treatment of human cervical cancers
05/08/2003US20030087268 Human lyases and associated proteins
05/08/2003US20030087266 IGs as modifiers of the p53 pathway and methods of use
05/08/2003US20030087253 Polynucleotide markers for ovarian cancer
05/08/2003US20030087249 93870, a human G-protein coupled receptor and uses therefor
05/08/2003US20030087246 Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereof
05/08/2003US20030087236 Method for generating diversity
05/08/2003US20030087234 Preparation of labeled biopolymers in situ; obtain bacteria, incubate with label and reaction mixture, separate, recover and analyze labeled bacteria
05/08/2003US20030086942 Inhibition of nucleocytoplasmic transport by vesicular stomatitis virus M protein-like polypeptides
05/08/2003US20030086940 For prophylaxis or therapy of rejection of xenotransplants are
05/08/2003US20030086939 Methods to improve immunogenicity of antigens and specificity of antibodies
05/08/2003US20030086938 Effecting presentation to the animal's immune system of an immunogenically effective amount of at least one analogue of autologous beta amyloid (A beta ) protein or autologous amyloid precursor
05/08/2003US20030086931 Therapy of cancers
05/08/2003US20030086929 Administering inhibitor of ATP synthase activity in a pharmaceutically effective amount for therapy and prophylaxis of prostate cancer
05/08/2003US20030086921 For therapy and prophylaxis of allergic conditions, autoimmune diseases and inflammatory diseases
05/08/2003US20030086919 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
05/08/2003US20030086918 For specific cleavage and purification of poly amino acids that have low solubilities
05/08/2003US20030086872 SUT-2 and SUT-3 genes, proteins and assays for inhibitors of lymphocyte adhesion
05/08/2003CA2756610A1 Methods for producing proteins having n-linked glycans comprising (sialyl-) lewis x or lacdinac structures
05/08/2003CA2465714A1 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003CA2465402A1 Anthrax antigenic compositions
05/08/2003CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003CA2462660A1 Nucleic acid-associated proteins
05/07/2003EP1308730A1 Method of detecting or assaying hbv
05/07/2003EP1308514A2 ICAM-4 Materials and Methods
05/07/2003EP1308509A1 Novel physiologically active peptide and use thereof
05/07/2003EP1308507A2 HCV anti-core monoclonal antibodies
05/07/2003EP1308461A2 Antibodies to beta-amyloids or their derivatives and use thereof
05/07/2003EP1307569A2 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use
05/07/2003EP1307568A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
05/07/2003EP1307560A2 Schizophrenia related gene and protein
05/07/2003EP1307557A2 Endothelial cell expression patterns
05/07/2003EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof
05/07/2003EP1307553A2 Mammalian dna binding membrane-associated protein-encoding gene and uses
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307483A2 Iapl-3 a protein inhibitor of apoptosis proteins
05/07/2003EP1307482A2 Two coloured fluorimetric protease assay
05/07/2003EP1307481A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression
05/07/2003EP1307480A2 Mutant trichosanthin
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP1307113A1 Oil seed processing
05/07/2003EP1272512A4 Immunokine composition and method
05/07/2003EP1218396A4 Antibodies specific for fullerenes
05/07/2003EP1064019A4 Chemically modified mutant enzymes and methods for producing them and screening them
05/07/2003EP0785993B1 Monoclonal antibodies to thymidine kinase isozymes
05/07/2003EP0762889B1 Heparin-binding protein for the treatment of sepsis
05/07/2003EP0749440B1 Method of isolating and purifying a biomacromolecule
05/07/2003EP0742720B1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
05/07/2003EP0683234B1 Antibody against beta-amyloid or their derivative and use thereof
05/07/2003EP0682699B1 FUNCTIONAL DOMAINS IN $i(FLAVOBACTERIUM OKEANOKOITES) (FOKI) RESTRICTION ENDONUCLEASE
05/07/2003EP0669982B1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
05/07/2003EP0627940B1 Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors
05/07/2003CN1416462A Techniques for growth and differentiatition of human pluripotent stem cells
05/07/2003CN1416461A Bacillus subtilis Var. chungkookjang producing high molecular weight poly-gumma-glutamic acid
05/07/2003CN1416350A Novel method for down-regulation of amyloid
05/07/2003CN1416348A Modified factor VIII
05/07/2003CN1415758A Technique for producing raw material of vancomycin hydrochloride
05/07/2003CN1415757A Method for extracting protein and chitin from fly maggot by using enzyme hydrolysis as well as preparing chitosan from chitin
05/07/2003CN1107871C Marking of products to establish identity and source testing box and products
05/06/2003US6559359 Plant extression vector for use as efficient gene transfer tool in genetic engineering
05/06/2003US6559285 Antibody for use in the treatment of cancer
05/06/2003US6559120 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
05/06/2003US6558950 Nucleotide sequences coding polypeptide for use in the treatment of programed cell death defects
05/06/2003US6558926 Method for production of tetanus toxin using media substantially free of animal products
05/06/2003US6558925 Stem cell inhibitor
05/06/2003US6558920 High expression system of proteins
05/06/2003US6558918 Nucleic acid that encode a cell growth regulatory protein
05/06/2003US6558913 Detection of preferential genotype in humans; obtain sample, incubate with probe, evaluate for homo/heterozygosity, evaluate for blood disorder
05/06/2003US6558676 Immunizing mammal with noninfectious material and isolating antibodies produced
05/06/2003US6558675 Mutant human hepatitis B viral strain and uses thereof
05/06/2003US6558672 Methods of making recombinant disulfide-stabilized polypeptide fragments having binding specificity
05/06/2003US6558661 Inhibiting binding of interferon-gamma to its native receptor
05/06/2003CA2199830C Expression and export technology of proteins as immunofusins
05/06/2003CA2153165C Recombinant anti-hiv antibody and process for preparing the same
05/06/2003CA2094144C Methods and applications for efficient genetic suppressor elements
05/06/2003CA2082160C Humanised and chimeric monoclonal antibodies
05/06/2003CA2031811C Toxoplasma gondii antigens, the preparation thereof and the use thereof
1 ... 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 ... 1125